You are here

Article info

Article menu
Download PDFPDF
Abstracts Accepted for Publication
Scleroderma, myositis and related syndromes
AB0625 The Clinical Significance of Antiphospholipid Antibodies in Systemic Sclerosis: A Systematic Review and Meta-Analysis

Authors

  • M. Merashli 1Rheumatology, NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK, Leeds, United Kingdom PubMed articlesGoogle scholar articles
  • P. Ames 2Vascular Disease Unit, Nova University, Lisbon, Portugal, Lisbon, Portugal PubMed articlesGoogle scholar articles

Citation

Merashli M, Ames P
AB0625 The Clinical Significance of Antiphospholipid Antibodies in Systemic Sclerosis: A Systematic Review and Meta-Analysis
Annals of the Rheumatic Diseases 2016;75:1118.

Publication history

  • First published July 15, 2016.
Online issue publication 
July 15, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions